LATEST NEWS
First-Line Metformin Use for DM Up; Sulfonylurea Use Down
 

Among patients with type 2 diabetes initiating antidiabetes drugs (ADDs), first-line use of metformin has increased since 2005, while sulfonylureas have remained the most popular second-line agent, rese...
Fri, 17 Nov 2017 BREAKING NEWS

FDA OKs Drug for Hemophilia A With Factor VIII Inhibitors
 

Hemlibra (emicizumab-kxwh) has been approved by the FDA to prevent or reduce the frequency of bleeding episodes among hemophilia A patients with Factor VIII inhibitors. The subcutaneously administered m...
Fri, 17 Nov 2017 BREAKING NEWS

Attributes of High-Value Oncology Practices Identified
 

(HealthDay News) Attributes that distinguish high-value oncology practices have been identified, according to a study published in JAMA Oncology. Three attributes — early and normalized palliative...
Fri, 17 Nov 2017 HEMATOLOGY & ONCOLOGY

FDA Investigation Linked to Drop in Codeine Rx for Children
 

The FDA investigation into the safety of codeine use by children, which culminated in a black box warning in February 2013, led to substantially decreased codeine prescribing to children after tonsillec...
Fri, 17 Nov 2017 BREAKING NEWS

Sentinel Lymph Node Biopsy Underused in High-Risk SCC
 

(HealthDay News) Sentinel lymph node biopsy (SLNB) is underused for high-risk squamous cell carcinoma (SCC) of the skin, according to a research letter in JAMA Dermatology. “Given the cost and mor...
Fri, 17 Nov 2017 DERMATOLOGY

Virtual Reality Effective for Post-Stroke Upper Extremity Rehab
 

(HealthDay News) Virtual reality (VR) training is as effective as conventional training for upper extremity rehabilitation after stroke, according to a study in Neurology. “Additional upper extrem...
Fri, 17 Nov 2017 NEUROLOGY

Drug Combo Doesn’t Lengthen Glioblastoma Survival
 

In patients with progressive glioblastoma, treatment with lomustine plus bevacizumab doesn't confer a survival advantage over treatment with lomustine alone, research in the New England Journal of Medic...
Fri, 17 Nov 2017 BREAKING NEWS

AHA: Supervised Exercise Ups 6-Minute Walking Distance in PAD
 

But no improvement seen with branulocyte-macrophage colony stimulating factor Supervised treadmill exercise, but not granulocyte-macrophage colony-stimulating factor (GM-CSF), improves six-minute walkin...
Fri, 17 Nov 2017 BREAKING NEWS